Alam mo ba na ang mga pagsubok ay maaaring matuklasan ang ilang mga kanser maaga, bago ka magkaroon ng anumang mga tanda o sintomas? Pakikipag-usap sa iyong provider ng kalusugan tungkol sa kung ang pag-screening para sa kanser ay tamang para sa iyo.
fda.gov/about-fda/onco…

The FDA Oncology Regulatory Affairs and Policy Program collaborates with CDER, CBER, and CDRH to develop and execute an integrated regulatory approach to enhance the cross-center coordination of oncology product clinical review. fda.gov/about-fda/onco…

On May 22, FDA will hold a virtual meeting of the ODAC Pediatric Oncology Subcommittee to discuss implementation and impact of the RACE for Children Act on drug development for pediatric patients with cancer, with speakers from EMA, academia, and industry.
fda.gov/advisory-commi…

FDA Oncology experts will be speaking at #ASCO24 ASCO Annual Meeting May 31-June 4 in Chicago. Add these talks to your calendar! fda.gov/about-fda/onco…

#OCETalks

FDA granted accelerated approval to tarlatamab-dlle for extensive stage small cell lung cancer with disease progression on or after platinum-based chemotherapy.

fda.gov/drugs/resource…

#OCENewsBurst

FDA Division of Oncology 2 took a break today to enjoy pizza and ice cream, good weather, and a Rick Pazdur selfie at FDA White Oak!

Bernardo Haddock Lobo Goulart Yun Oh Gautam Mehta, MD PJ Vellanki Joseph Gibbons Jeevan Puthiamadathil Justin Malinou

About DO2: fda.gov/about-fda/cent…
#OCECareers

Looking for oncology drug development guidance? We can help.
fda.gov/about-fda/onco…
#FDAGuidance

Save the date & register for the FDA 9th Annual Clinical Outcome Assessment in Cancer Clinical Trials Workshop to discuss modernizing tolerability assessment in cancer clinical trials. June 25, 11am ET. #OCEOutcomes24 Vishal Bhatnagar, MD Paul Kluetz
Click ➡️ : bit.ly/3UEFsyA

OCE ENGAGE: An FDA Oncology Center of Excellence Project Community quarterly newsletter for patients living with cancer, survivors, advocates and consumers. Sign up for free: fda.gov/about-fda/proj…

#OCEProjectCommunity #ConversationsOnCancer #BlackFamCan #AACR24 #ASCO24

FDA has granted accelerated approval to lisocabtagene maraleucel for adults with relapsed or refractory follicular lymphoma who have received two or more prior lines of systemic therapy.
fda.gov/drugs/resource…

#OCENewsBurst

✨ Please add your feedback on ideas for #PragmaticTrials in Oncology submitted to #OCEProject5in5 . Pick your favorites, comment, & propose your own to help shape the future of oncology drug development! 💡
Click here ⤵️ shareyourvoice.ideascalegov.com/c/landing

FDA Oncology Center Project 5 in 5 crowdsourcing initiative is seeking 5 clinically relevant questions for 5 pragmatic clinical trials, using FDA-approved therapies!
💡 Got any ideas? Sign up and submit ideas here ⤵️ shareyourvoice.ideascalegov.com/c/

#OCEProject5in5 #PragmaticTrials

Participate in our June #ConversationsonCancer on June 13, coinciding with the start of National Black Family Cancer Awareness Week, themed: Engaging the Generations. Together, we can combat this deadly disease. #BlackFamCan #OCEProjectCommunity

surveymonkey.com/r/SKJGDZD

您是否知道，在您出現任何體征或症狀之前，有一些檢查可以及早發現某些癌症？請與您的醫療服務提供者討論您是否適合進行癌症篩查。在 Project ASIATICA | FDA 上查看這些可用資源。
fda.gov/about-fda/onco…

Want to know what's happening at FDA Oncology? Read the monthly OCE PULSE! Check it out for updates on drug approvals in oncology and hematologic malignancies, public events, and professional training opportunities.
fda.gov/about-fda/onco…

#OCEProjectSocrates #AACR24 #ASCO24